Regeneron: PCSK9s Drowning In Paperwork
A common problem is plaguing both Regeneron Pharmaceuticals Inc. and Amgen Inc. – paperwork, specifically, the abundance of paperwork patients and physicians need to fill out to prescribe a PCSK9 inhibitor.
A common problem is plaguing both Regeneron Pharmaceuticals Inc. and Amgen Inc. – paperwork, specifically, the abundance of paperwork patients and physicians need to fill out to prescribe a PCSK9 inhibitor.